0001567619-20-002450.txt : 20200207 0001567619-20-002450.hdr.sgml : 20200207 20200207170054 ACCESSION NUMBER: 0001567619-20-002450 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200205 FILED AS OF DATE: 20200207 DATE AS OF CHANGE: 20200207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAZELSKY JONATHAN JAY CENTRAL INDEX KEY: 0001556270 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 20588243 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 FORMER NAME: FORMER CONFORMED NAME: MAZELSKY JAY DATE OF NAME CHANGE: 20120815 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 doc1.xml FORM 4 X0306 4 2020-02-05 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001556270 MAZELSKY JONATHAN JAY ONE IDEXX DRIVE WESTBROOK ME 04092 1 1 0 0 President & CEO Common Stock 2020-02-05 4 M 0 13824 45.84 A 50685 D Common Stock 2020-02-05 4 S 0 1145 275.7245 D 49540 D Common Stock 2020-02-05 4 S 0 1337 276.7072 D 48203 D Common Stock 2020-02-05 4 S 0 3354 277.8769 D 44849 D Common Stock 2020-02-05 4 S 0 1676 279.0054 D 43173 D Common Stock 2020-02-05 4 S 0 100 280.133 D 43073 D Common Stock 2020-02-05 4 S 0 388 281.9705 D 42685 D Non-Qualified Stock Option (right-to-buy) 45.84 2020-02-05 4 M 0 13824 D 2020-02-13 Common Stock 13824 0 D Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Represents the weighted average price of the shares sold ranging from a low of $275.24 to a high of $276.21 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $276.30 to a high of $277.27 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $277.50 to a high of $278.48 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $278.655 to a high of $279.642 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $281.87 to a high of $282.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Grant of option to buy 13,014 shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2014 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Not applicable. /s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky 2020-02-07